Showing results (1071-1080 of 2,915) with videos related to
Sort By:
Pageof 292
Cancer Gene Therapy|November 8, 2008
An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor modelsS Dharmapuri, L Aurisicchio, P Neuner, et al.Cancer Gene Therapy|December 17, 2011
Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcomaN Rainusso, V S Brawley, A Ghazi, et al.Cancer Gene Therapy|December 24, 2011
Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancerT T Sahin, H Kasuya, N Nomura, et al.Cancer Gene Therapy|April 28, 2012
Activation of a glioma-specific immune response by oncolytic parvovirus Minute Virus of Mice infectionS P Grekova, Z Raykov, R Zawatzky, et al.Cancer Gene Therapy|November 26, 2011
Oncolytic poxvirus armed with Fas ligand leads to induction of cellular Fas receptor and selective viral replication in FasR-negative cancerM Sathaiah, P Thirunavukkarasu, M E O'Malley, et al.Cancer Gene Therapy|April 14, 2012
Combining transfer of TTF-1 and Pax-8 gene: a potential strategy to promote radioiodine therapy of thyroid carcinomaD Mu, R Huang, S Li, et al.Cancer Gene Therapy|April 24, 2012
Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-βS Naik, R Nace, G N Barber, et al.Cancer Gene Therapy|September 17, 2011
D-amino acid oxidase gene therapy sensitizes glioma cells to the antiglycolytic effect of 3-bromopyruvateS M El Sayed, R M Abou El-Magd, Y Shishido, et al.Cancer Gene Therapy|September 10, 2011
Treatment of mesothelioma with gene-modified PA1STK cells and ganciclovir: a phase I studyP Schwarzenberger, P Byrne, R Gaumer, et al.Cancer Gene Therapy|September 10, 2011
Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal abilityW Gu, E Yeo, N McMillan, et al.Pageof 292